Stephanie Guey

Paris, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 47 publications

Risk of Clinical Events in Presymptomatic Familial Cerebral Cavernous Malformations.

Risk of Clinical Events in Presymptomatic Familial Cerebral Cavernous Malformations.

Journal: European journal of neurology

Published: March 04, 2026

Tocotrienol-rich vitamin E complex in CADASIL (T3CAD): a randomised, double-blind, placebo-controlled trial.

Tocotrienol-rich vitamin E complex in CADASIL (T3CAD): a randomised, double-blind, placebo-controlled trial.

Journal: EClinicalMedicine

Published: February 21, 2026

Late Cognitive or Mood Alterations With 'Status Cribrosum' and Diffuse White Matter Lesions: A New Cerebral Small Vessel Disease Phenotype Associated With Rare COL4A1 Variants Located Within Exon 23.

Late Cognitive or Mood Alterations With 'Status Cribrosum' and Diffuse White Matter Lesions: A New Cerebral Small Vessel Disease Phenotype Associated With Rare COL4A1 Variants Located Within Exon 23.

Journal: European journal of neurology

Published: January 22, 2026

COL4A1 and COL4A2 Gene Duplication or Triplication as a Genetic Cause of Cerebral Small Vessel Disease in Adults.

COL4A1 and COL4A2 Gene Duplication or Triplication as a Genetic Cause of Cerebral Small Vessel Disease in Adults.

Journal: Stroke

Published: January 02, 2026

Clinical Impact of NOTCH3 Variant Location After First Stroke in CADASIL.

Clinical Impact of NOTCH3 Variant Location After First Stroke in CADASIL.

Journal: Annals of clinical and translational neurology

Published: December 26, 2025

Simple MRI Lesion Levels Improve Two-Year Prognostic Accuracy Beyond Clinical History in CADASIL.

Simple MRI Lesion Levels Improve Two-Year Prognostic Accuracy Beyond Clinical History in CADASIL.

Journal: Stroke

Published: December 24, 2025

Response to the Letter to the Editor: "Reaffirming Caution-The Unacceptable Vasoconstrictive Risk of CGRP-Related Therapies in Moyamoya Angiopathy".

Response to the Letter to the Editor: "Reaffirming Caution-The Unacceptable Vasoconstrictive Risk of CGRP-Related Therapies in Moyamoya Angiopathy".

Journal: European journal of neurology

Published: November 12, 2025

Lifetime Risk of First Symptomatic ICH or Seizure in Familial Cerebral Cavernous Malformations: A Multicenter Patient Data Analysis.

Lifetime Risk of First Symptomatic ICH or Seizure in Familial Cerebral Cavernous Malformations: A Multicenter Patient Data Analysis.

Journal: Neurology

Published: July 10, 2025

The Spectrum of Headaches in Moyamoya Angiopathy: From Mechanisms to Management Strategies-A Consensus Review From the NEUROVASC Working Group.

The Spectrum of Headaches in Moyamoya Angiopathy: From Mechanisms to Management Strategies-A Consensus Review From the NEUROVASC Working Group.

Journal: European journal of neurology

Published: May 31, 2025

Intracerebral Hemorrhage in Patients With CADASIL: Additive Impact of the NOTCH3 R544C Variant and Hypertension?

Intracerebral Hemorrhage in Patients With CADASIL: Additive Impact of the NOTCH3 R544C Variant and Hypertension?

Journal: Stroke

Published: April 24, 2025

Cerebral Venous Thrombosis and Nitrous Oxide Intoxication: Report of Two Cases and Review of the Literature.

Cerebral Venous Thrombosis and Nitrous Oxide Intoxication: Report of Two Cases and Review of the Literature.

Journal: Brain and behavior

Published: January 01, 2025

Determining Clinical Disease Progression in Symptomatic Patients With CADASIL.

Determining Clinical Disease Progression in Symptomatic Patients With CADASIL.

Journal: Neurology

Published: December 17, 2024

Showing 1-12 of 47

Last Updated: 09/26/2026